What smart money is saying about Ligand Pharmaceuticals Incorporated
No fund has written a full thesis on Ligand Pharmaceuticals Incorporated in our archive, but 5 fund letters report a position in it, most recently Granahan Investment Management Small Cap Focused Growth Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
Position history
Between Q1 2026 and Q3 2026, 5 fund letters reported a position in Ligand Pharmaceuticals Incorporated, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 3 | 1 | 0 | 0 |
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q1 2026 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 5 positions · 1 move
- September 2026
Listed in Granahan Investment Management Small Cap Focused Growth Strategy’s reported holdings.
Ligand Pharmaceuticals Incorporated - September 2026
“Ligand Pharmaceuticals (LGND) collects royalties on a diversified portfolio of partnered therapies; we added to the position as we gained conviction in the company.”
Ligand Pharmaceuticals Incorporated - September 2026
“TOP 10 HOLDINGS (%)* Silicon Motion Technology Corp. 3.02 Ligand Pharmaceuticals, Inc. 3.02 MYR Group, Inc.”
Ligand Pharmaceuticals Incorporated - June 2026
“FUND MANAGEMENT TOP 10 HOLDINGS (%)* Silicon Laboratories, Inc. 3.34 WisdomTree, Inc. 3.15 Ligand Pharmaceuticals, Inc. 3.10 JBT Marel Corp 2.48 MYR Group, Inc.”
Ligand Pharmaceuticals Incorporated - March 2026
“FUND MANAGEMENT TOP 10 HOLDINGS (%)* Option Care Health, Inc. 2.80 Ligand Pharmaceuticals, Inc. 2.54 JBT Marel Corporation”
Ligand Pharmaceuticals Incorporated
Read the letters behind these Ligand Pharmaceuticals Incorporated positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→